Gemcitabine 40 mg / ml concentrate for solution for Infusion
- Licence status
- Withdrawn: 26/06/2019
- Active substances
- Gemcitabine
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- PA2059/039/004
- Licence holder
- Fresenius Kabi Deutschland GmbH
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L01BC Pyrimidine analogues, L01BC05 gemcitabine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 23/11/2012